SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway
Liquan Yu, Hong Xu, Song Zhang, Jiangming Chen, Zhongshan Yu
Topics & Concepts
CisplatinPI3K/AKT/mTOR pathwayProtein kinase BHepatocellular carcinomaBlotCancer researchApoptosisViability assayChemistryMolecular biologyBiologyMedicineInternal medicineBiochemistryChemotherapyGeneCancer, Hypoxia, and MetabolismLiver physiology and pathologyHepatocellular Carcinoma Treatment and Prognosis